ACR Open Rheumatology

Scope & Guideline

Pioneering advancements in rheumatic disease understanding and treatment.

Introduction

Delve into the academic richness of ACR Open Rheumatology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationACR OPEN RHEUMATOL / ACR Open Rheumatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

ACR Open Rheumatology aims to advance the understanding and treatment of rheumatic diseases through rigorous research and scholarly communication. The journal encompasses a wide range of topics related to rheumatology, emphasizing the importance of clinical practice, patient-oriented research, and innovative methodologies.
  1. Clinical and Translational Research:
    The journal publishes studies that bridge laboratory research and clinical practice, focusing on the mechanisms of rheumatic diseases and their treatments.
  2. Patient-Centered Outcomes:
    Research highlighting patient-reported outcomes, quality of life, and treatment adherence is emphasized, showcasing the importance of patient perspectives in rheumatology.
  3. Innovative Therapeutics and Interventions:
    The journal includes studies on new drugs, biologics, and therapeutic interventions, providing insights into efficacy, safety, and practical applications.
  4. Epidemiology and Health Disparities:
    Research addressing the epidemiology of rheumatic diseases, including risk factors, comorbidities, and disparities in care, is a core focus.
  5. Diagnostic and Imaging Advances:
    The journal features studies on novel diagnostic techniques and imaging modalities that enhance the understanding and management of rheumatic conditions.
  6. Health Services and Policy Research:
    Research on healthcare delivery, policy implications, and the economic burden of rheumatic diseases is included to inform practice and improve patient care.
ACR Open Rheumatology has demonstrated a dynamic evolution in its focus areas, reflecting the changing landscape of rheumatology. Recent publications indicate emerging trends and themes that are gaining traction.
  1. Digital Health and Telemedicine:
    With the rise of telehealth, studies exploring the efficacy and patient satisfaction of remote care models have increased significantly, particularly in response to the COVID-19 pandemic.
  2. Mental Health and Psychosocial Aspects:
    There is a growing emphasis on the psychosocial dimensions of rheumatic diseases, including mental health impacts, which are increasingly recognized as crucial in patient care.
  3. Integrative and Complementary Therapies:
    Research exploring the use of complementary and integrative therapies alongside traditional treatments is on the rise, reflecting patient interest in holistic care.
  4. Machine Learning and Data Analytics:
    The application of machine learning techniques for predicting outcomes and personalizing treatments is emerging as a significant area of research.
  5. Health Disparities and Social Determinants of Health:
    There is an increasing focus on understanding how social determinants affect the incidence, treatment access, and outcomes for patients with rheumatic diseases.
  6. Patient Empowerment and Shared Decision-Making:
    Studies promoting patient involvement in treatment decisions and self-management strategies are gaining importance, highlighting a shift towards more patient-centered care.

Declining or Waning

While ACR Open Rheumatology continues to cover a broad range of topics, certain areas have shown a decline in publication frequency or emphasis in recent years. The following themes appear to be waning.
  1. Traditional Pharmacotherapy Studies:
    There has been a noticeable decline in studies focusing solely on conventional disease-modifying antirheumatic drugs (DMARDs) without the integration of newer therapies or comparative effectiveness research.
  2. Basic Science Research:
    The journal has shifted towards more clinically relevant studies, leading to a decrease in purely basic science research that does not directly relate to patient outcomes.
  3. Single-Center Studies:
    There is a trend away from publication of single-center studies, with a preference for multi-center collaborations that enhance the generalizability of findings.
  4. Longitudinal Cohort Studies without Intervention:
    While cohort studies remain important, those that do not investigate interventions or outcomes have decreased, reflecting a broader interest in actionable research.
  5. Focus on Rare Diseases:
    Research on rare rheumatic conditions, while still valuable, has seen a decrease in frequency, possibly due to the growing interest in more prevalent diseases or conditions.

Similar Journals

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Exploring New Horizons in Rheumatology Science
Publisher: TAYLOR & FRANCIS LTDISSN: 0300-9742Frequency: 6 issues/year

The Scandinavian Journal of Rheumatology, published by Taylor & Francis Ltd, is a prestigious peer-reviewed journal dedicated to advancing research in the fields of rheumatology, immunology, and related disciplines. With an ISSN of 0300-9742 and an E-ISSN of 1502-7732, this journal has established itself as a vital platform for disseminating significant findings and innovative approaches in the management of rheumatic diseases since its inception in 1959. As a recognized scholarly outlet, it currently resides within the Q2 category for Medicine (miscellaneous) and ranks #39 out of 73 in Rheumatology according to the 2023 Scopus assessments. This reflects the journal's commitment to high-quality research and its relevance in the scientific community. Although it does not provide Open Access options, the journal's rigorous selection process ensures that only the most impactful research reaches its audience, making it a crucial resource for researchers, clinicians, and students engaged in the exploration of rheumatological and immunological challenges. The journal's broad scope encompasses ongoing studies, clinical trials, and reviews that aim to enhance understanding and treatment of rheumatic conditions, promoting collaboration and knowledge-sharing among professionals in the field.

MEDICAL PRINCIPLES AND PRACTICE

Unlocking insights, transforming practice.
Publisher: KARGERISSN: 1011-7571Frequency: 6 issues/year

Medical Principles and Practice is a renowned journal within the field of health sciences, disseminating cutting-edge research and insights since its inception in 1989. Published by Karger in Switzerland, this Open Access journal has committed itself to making valuable medical knowledge freely accessible to the global research community since 2013. With an impressive impact factor and ranked in the Q2 category of Medicine (miscellaneous) for 2023, it holds a prestigious position, currently occupying the 70th rank out of 636 in the Scopus category of General Medicine, placing it in the 89th percentile overall. The journal’s dedication to merging theoretical principles with practical applications makes it a critical resource for researchers, healthcare professionals, and students aiming to enhance their understanding and application of medical knowledge. Published in Basel, Switzerland, this journal paves the way for pioneering discussions and advancements in medical practice, ensuring that its audience remains at the forefront of the rapidly evolving healthcare landscape.

RHEUMATOLOGY

Transforming Treatment with Pioneering Research in Rheumatology
Publisher: OXFORD UNIV PRESSISSN: 1462-0324Frequency: 12 issues/year

RHEUMATOLOGY, published by Oxford University Press, is a leading journal in the fields of Pharmacology and Rheumatology, recognized for its significant contribution to advancing the understanding and treatment of rheumatic diseases. With an impressive impact factor and ranking within the top quartiles for both medical pharmacology and rheumatology, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals. The journal spans an extensive publication history, with contributions from 1952 to 1995 and from 1998 to 2024, reflecting its enduring commitment to disseminating high-quality research. The Open Access option allows for broader dissemination of knowledge, enhancing the visibility of groundbreaking studies. Positioned in the United Kingdom, RHEUMATOLOGY not only offers valuable insights into the latest therapeutic advancements and clinical guidelines but also fosters collaboration across disciplines, ensuring that practitioners stay at the forefront of innovation in the management of rheumatic conditions.

Modern Rheumatology

Exploring Breakthroughs in Rheumatic Disease Research
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Advancing knowledge in rheumatology and immunology.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

Advances in Rheumatology

Elevating rheumatology research for a healthier future.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Archives of Rheumatology

Empowering researchers to reshape rheumatic disease management.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Dermatology Research and Practice

Exploring groundbreaking research in dermatology.
Publisher: HINDAWI LTDISSN: 1687-6105Frequency: 1 issue/year

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

Kidney360

Redefining nephrology through open-access knowledge.
Publisher: AMER SOC NEPHROLOGYISSN: 2641-7650Frequency: 12 issues/year

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

Pediatric Rheumatology

Advancing pediatric care through groundbreaking research.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.